David Edward Johnson - Net Worth and Insider Trading

David Edward Johnson Net Worth

The estimated net worth of David Edward Johnson is at least $25 Million dollars as of 2024-05-08. David Edward Johnson is the Director of Exelixis Inc and owns about 1,118,906 shares of Exelixis Inc (EXEL) stock worth over $25 Million. Details can be seen in David Edward Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Edward Johnson has not made any transactions after 2024-02-21 and currently still holds the listed stock(s).

Transaction Summary of David Edward Johnson

To

David Edward Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Edward Johnson owns 5 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Standard BioTools Inc (LAB) , and Liquidia Corp (LQDA) among others .

Click here to see the complete history of David Edward Johnson’s form 4 insider trades.

Insider Ownership Summary of David Edward Johnson

Ticker Comapny Transaction Date Type of Owner
AMAG AMAG Pharmaceuticals Inc 2020-06-02 director & 10 percent owner
LAB Standard BioTools Inc 2021-05-07 10 percent owner
LQDA Liquidia Corp 2021-04-12 10 percent owner
2024-02-21 director
2023-08-01 10 percent owner

David Edward Johnson Latest Holdings Summary

David Edward Johnson currently owns a total of 1 stock. David Edward Johnson owns 1,118,906 shares of Exelixis Inc (EXEL) as of February 21, 2024, with a value of $25 Million.

Latest Holdings of David Edward Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EXEL Exelixis Inc 2024-02-21 1,118,906 22.17 24,806,146

Holding Weightings of David Edward Johnson


David Edward Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, David Edward Johnson has made a total of 3 transactions in Exelixis Inc (EXEL) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Exelixis Inc is the acquisition of 190,000 shares on February 21, 2024, which cost David Edward Johnson around $4 Million.

Insider Trading History of David Edward Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Edward Johnson Trading Performance

GuruFocus tracks the stock performance after each of David Edward Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Edward Johnson is 0.46%. GuruFocus also compares David Edward Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Edward Johnson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Edward Johnson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Edward Johnson

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.37
Relative Return to S&P 500(%) 8.22

David Edward Johnson Ownership Network

Ownership Network List of David Edward Johnson

No Data

Ownership Network Relation of David Edward Johnson


David Edward Johnson Owned Company Details

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

David Edward Johnson is the director & 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

David Edward Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for David Edward Johnson. You might contact David Edward Johnson via mailing address: 590 Madison Avenue, New York Ny 10022.

Discussions on David Edward Johnson

No discussions yet.